Basta Steven L
SEC-identified person · CIK 1417397 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Phathom Pharmaceuticals, Inc. PHAT | Director · President and CEO | filed 2025–2026 |
| Vyne Therapeutics Inc. VYNE | Director · See Remarks | filed 2018–2025 |
| Viveve Medical, INC. plcsf | Director | filed 2018–2023 |
| Kalvista Pharmaceuticals, Inc. KALV | Director | filed 2015–2016 |
| Bioform Medical INC BFRM | Director · Chief Executive Officer | filed 2007–2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.